At this time, posts about KainosMed are rapidly increasing on portals and stock communities. Today, foreigners have tentatively purchased a net 1,000 shares of KainosMed, while institutions have sold a net 648,000 shares.

As of 11:30 AM on the 10th, KainosMed's stock price is 4,785 KRW, up 13.25% from the previous day, with a trading volume of 21,964,785 shares, which is 300.65% of the 5-day average trading volume. On June 9, KainosMed was a market topic as the "Rebound... Leading clinical developer of Parkinson's disease treatment."

In addition to KainosMed, posts by investors are also rapidly increasing regarding Shinpung Pharmaceutical Preferred (019175), Ilyang Pharmaceutical Preferred (007575), and Myungmoon Pharmaceutical (017180).

※Source: AI Investment Assistant AI Lassi

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing